Skip to main content
Equibles

Dr. Matthew Angel

CEO

Ernexa Therapeutics Inc. (ERNA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Ernexa Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get ERNA alerts

About Dr. Matthew Angel

Dr. Matthew Angel is recorded as CEO at Ernexa Therapeutics Inc. (ERNA) since August 9, 2023. Ernexa Therapeutics Inc. reported in an 8-K filed December 20, 2023 that Dr. Matthew Angel resigned as President and Chief Executive Officer, effective December 31, 2023. Ernexa Therapeutics Inc. reported in an 8-K filed August 10, 2023 that Dr. Matthew Angel was appointed President and Chief Executive Officer (principal executive officer), effective August 9, 2023. Ernexa Therapeutics Inc. reported in an 8-K filed August 10, 2023 that Dr. Matthew Angel resigned as Board, effective August 4, 2023. Equibles holds 5 filed executive changes naming Dr. Matthew Angel; each is listed under recent activity with its source filing. Ernexa Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ernexa Therapeutics Inc. includes Matt Angel, Ph.D. (CEO), Sanjeev Luther (CEO and Board Member), Allen Wolff (Chairman and Board Member) and 7 others.

“On December 19, 2023, Dr. Matthew Angel notified Eterna Therapeutics Inc. (the “Company”) that he was resigning from his position as the Company’s President and Chief Executive Officer, effective on December 31, 2023.”
Ernexa Therapeutics Inc. Form 8-K, filed December 20, 2023 · Read the filing
“At a meeting of the Board on August 9, 2023, the Board reappointed Dr. Angel as the Company's President and Chief Executive Officer (principal executive officer) on the same terms on which Dr. Angel served immediately prior to his resignation.”
Ernexa Therapeutics Inc. Form 8-K, filed August 10, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Ernexa Therapeutics Inc.

Recent activity